BioCentury
ARTICLE | Clinical News

Vasomax phentolamine data

May 13, 1996 7:00 AM UTC

Researchers presented results of ZONA's 177-patient Phase II study in Germany of Vasomax at the American Urological Association meeting in Orlando, Fla. The trial measured erectile response in an at-home setting.

The highest dose tested, 60 mg, was generally well-tolerated, with 5 of 45 patients reporting adverse events. No patients on the 40 mg dose discontinued the study due to adverse events. ...